CSX heads into the final stretch before its July 21 earnings with an unusual mix: analyst conviction building on one side, a subtle short rebuild on the other, while options traders are actually the most bullish they've been in months.
The clearest signal this week comes from the analyst desk. BofA's Ken Hoexter — acting within the past 24 hours — raised his price target on CSX from $51 to $53 while holding his Buy rating. That move keeps BofA the most bullish major firm covering the stock, and it continues a pattern from late April when a wave of target upgrades followed Q1 results. Baird, RBC, TD Cowen, Wells Fargo, and Barclays all lifted targets then, with Wells Fargo pushing to $50. The consensus mean price target now runs at $46.16 — nearly in line with the current $46.90 price — which means the Street is split between those who think fair value is roughly here and those, like BofA and Wells Fargo, who see 7-13% additional upside. The bull case centers on CSX's operational efficiency gains: Q1 delivered a 430 basis-point improvement in operating ratio and management raised margin guidance for the full year. Bears point to coal market softness, potential plant retirements on the Eastern network, and the possibility that volume growth stalls in a slower macro. The forward earnings picture is more constructive — CSX ranks in the 91st percentile for 12-month forward EPS growth expectations — but the EV/EBITDA multiple at 14.5x has drifted slightly lower over the past month, suggesting the market isn't paying up for that optimism yet.
Options positioning tells the most interesting story in the short-term setup. Call activity has overwhelmed puts, pushing the put/call ratio to 0.43 — roughly a full standard deviation below the 20-day average of 0.59 and close to the lowest reading of the past year (the 52-week floor is 0.28). As recently as early June, the PCR was running near 0.78, reflecting considerably more defensive positioning. That shift toward calls since late May is notable in isolation. Borrow conditions reinforce the low-pressure environment: cost to borrow has fallen 28% over the past week to just 0.38%, near its cheapest level in months, and availability is effectively uncapped — the lending pool is nowhere close to being exhausted. With availability at the capped maximum, there is no squeeze dynamic in the borrow market.
Short interest tells a slightly different story, and it's worth naming the contrast. SI climbed roughly 9.6% over the past week, rising back to around 36.9 million shares, or about 2% of the free float. That's not high in absolute terms — the level sits in the low-to-normal range historically — but the direction of travel changed abruptly. Through most of May, short sellers were covering: SI fell from above 41 million shares in early May to around 33.6 million by June 8. The sharp rebuild last week, from 33.6 million back toward 37 million, suggests a subset of traders used the stock's month-long rally to re-enter short positions. Given borrow is this cheap and availability this loose, there is no friction preventing that accumulation from continuing. The ORTEX short score of 32.1 reflects a low-short-pressure environment overall, but the week's direction of travel is worth monitoring.
The one insider signal worth noting is mixed in character. CFO Kevin Boone sold 136,708 shares on June 3 for roughly $6.4 million. That's a large sale by dollar value. It follows a CEO purchase back in March — Stephen Angel bought 25,000 shares at $40.27 — which is now sitting on a gain of roughly 16%. The 90-day net insider position is technically a net buy (about 172,000 shares net), but the recent CFO sale near the highs and the Chairman's simultaneous $464,000 sale suggest insiders are taking some chips off the table after the stock's recovery from March lows.
The next focal point is the Q1 earnings release on July 21. The last print — the April 22 Q1 report — drove a 6.5% one-day jump, the strongest near-term reaction in recent history. The May print moved barely at all. With call positioning now clearly dominant and BofA refreshing its target just this morning, the setup into July is less about whether CSX is executing and more about whether volume trends, particularly in coal and intermodal, show enough resilience to justify targets above $50.
See the live data behind this article on ORTEX.
Open CSX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.